Patients with asplenia have reduced levels of IgM memory B cells and IgM anti-pneumococcal antibodies, causing reduced ability to produce protective antibodies against polysaccharide antigens, and hence, possible vaccine failure [91,92]. The gene discussed is CD40LG; the disease is familial isolated congenital asplenia.